Study finds chlorophyll can help prevent cancer - but questions traditional research methods

January 12, 2012, Oregon State University
Study finds chlorophyll can help prevent cancer - but questions traditional research methods

A recent study at Oregon State University found that the chlorophyll in green vegetables offers protection against cancer when tested against the modest carcinogen exposure levels most likely to be found in the environment.

However, actually increases the number of tumors at very high exposure levels.

Beyond confirming the value of chlorophyll, the research raises serious questions about whether traditional lab studies done with mice and high levels of are providing accurate answers to what is a real health risk, what isn't, and what dietary or pharmaceutical approaches are useful.

The findings, published in the journal Food and , were done using 12,360 rainbow trout as laboratory models, instead of more common . Rodent studies are much more expensive, forcing the use of fewer specimens and higher carcinogen exposures.

"There's considerable evidence in epidemiologic and other clinical studies with humans that chlorophyll and its derivative, , can protect against cancer," said Tammie McQuistan, a research assistant working with George Bailey, a professor emeritus in the Linus Pauling Institute at OSU.

"This study, like others before it, found that chlorophyll can reduce tumors, up to a point," McQuistan said. "But at very high doses of the same carcinogen, chlorophyll actually made the problem worse. This questions the value of an approach often used in studying cancer-causing compounds."

OSU experts in recent years have become pioneers in the use of rainbow trout as a model for biomedical research, in part because the fish react in similar ways to those of rodents, but also because scientists can use thousands of them – instead of dozens or hundreds of mice – and do experiments that would not otherwise be possible.

In that context, this study raises questions about a fundamental premise of much medical research – expose a laboratory animal to a compound at high levels, observe the result, and predict that a proportional amount of that same result would be present at low levels of exposure.

In one part of the study, trout were exposed to fairly moderate levels of a known carcinogen, but also given chlorophyll. This reduced their number of liver tumors by 29-64 percent, and stomach tumors by 24-45 percent. But in another part of the study, using much higher and unrealistic doses of the same carcinogen, the use of chlorophyll caused a significant increase in the number of tumors.

In other words, traditional research with small numbers of animals fed very high doses of a carcinogen might conclude that chlorophyll has the potential to increase human cancer risk. This study, and other evidence and trials, concludes just the opposite.

It also found that the protective mechanism of chlorophyll is fairly simple – it just binds with and sequesters carcinogens within the gastrointestinal tract until they are eliminated from the body. At the lower carcinogen doses and cancer rates relevant to humans, chlorophyll was strongly protective.

"The central assumption of such experiments is that intervention effects at high carcinogen dose will apply equally at lower carcinogen doses," the researchers wrote in their report. "Contrary to the usual assumption, the outcomes in the major target organ were strikingly dependent on carcinogen dose."

OSU experts have argued that in some studies can produce better, more accurate, real-world results compared to traditional rodent animal models and relevant to humans, because many more specimens can be used and lower doses of toxins studied. Experiments done with fish may be about 20 times cheaper and, in the end, more scientifically valid, they say.

"Results derived at high carcinogen doses and high tumor responses may be irrelevant for human intervention," the scientists said in their conclusion.

Explore further: Cancer from fetal exposure to carcinogens depends on dose, timing

Related Stories

Cancer from fetal exposure to carcinogens depends on dose, timing

December 15, 2011
The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed.

Estrogen-targeting drug combo may help prevent lung cancer

January 9, 2012
A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice, according to results from a preclinical study.

Recommended for you

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.